Charles Moore
Stock Analyst at Robert W. Baird
(0.35)
# 4,507
Out of 5,085 analysts
10
Total ratings
11.1%
Success rate
-23.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Charles Moore
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CTNM Contineum Therapeutics | Downgraded: Hold | $19 → $14 | $9.16 | +52.84% | 4 | Oct 14, 2026 | |
| DNLI Denali Therapeutics | Reiterated: Buy | $34 | $19.02 | +78.76% | 3 | Aug 7, 2026 | |
| DRUG Bright Minds Biosciences | Reiterated: Buy | $142 → $126 | $54.87 | +129.65% | 3 | Feb 13, 2026 |
Contineum Therapeutics
Oct 14, 2026
Downgraded: Hold
Price Target: $19 → $14
Current: $9.16
Upside: +52.84%
Denali Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $34
Current: $19.02
Upside: +78.76%
Bright Minds Biosciences
Feb 13, 2026
Reiterated: Buy
Price Target: $142 → $126
Current: $54.87
Upside: +129.65%